Technological aspect of the production of live dysentery vaccines for oral administration
- PMID: 1805499
Technological aspect of the production of live dysentery vaccines for oral administration
Abstract
An experimental technology for the production of live freeze-dried vaccines prepared from attenuated Shigella flexneri 2a and Shigella sonnei I strains was developed. It is based on the cultivation of bacterial strains in a fermentor under conditions which ensure high yields. The strains grow in S-form, their antigenic structure is preserved and they remain non-virulent. The attenuating markers are stable. The freeze-dried vaccines retain good immunogenicity when applied intra-intestinally to rats.
Similar articles
-
[Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].Acta Microbiol Acad Sci Hung. 1974;21(1-2):63-9. Acta Microbiol Acad Sci Hung. 1974. PMID: 4216253 Russian. No abstract available.
-
Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.Vaccine. 2007 Mar 8;25(12):2269-78. doi: 10.1016/j.vaccine.2006.11.067. Epub 2006 Dec 20. Vaccine. 2007. PMID: 17229494
-
Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.Acta Microbiol Hung. 1990;37(4):359-66. Acta Microbiol Hung. 1990. PMID: 2099082
-
Self-experiments with ingestion of various bacteria.Acta Microbiol Acad Sci Hung. 1974;21(1-2):45-62. Acta Microbiol Acad Sci Hung. 1974. PMID: 4216252 Review. No abstract available.
-
Shigellosis: the current status of vaccine development.Curr Opin Infect Dis. 2008 Jun;21(3):313-8. doi: 10.1097/QCO.0b013e3282f88b92. Curr Opin Infect Dis. 2008. PMID: 18448978 Review.